CompletedNot Applicable

A Trial of Cognitive Behavioral Therapy in Familial Dysautonomia

United States15 participantsStarted 2016-12-06

Plain-language summary

To determine the effect of cognitive behavioral therapy (CBT) in the severity of anxiety and depression in adult patients with familial dysautonomia. Patients will be enrolled in an 8-week CBT program. All CBT sessions will be done either in person at the NYU Dysautonomia Center or over the phone to help accommodate disability and potential physical limitations of our patient population.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Diagnosis of FD (genetically confirmed) * DSM-V criteria of major depressive disorder OR anxiety disorder * STAI score ≥ 25 OR a PHQ-9 depression scale score ≥ 5 or greater * Willing and able to complete 8 CBT sessions * Maintain constant psychoactive medication through out study and no concurrent talk therapy from another therapist. Exclusion Criteria: * Currently suicidal or having current suicidal ideations * Currently under psychiatric treatment for depression or anxiety * Have started any psychoactive medication within 3 months prior to screening

What they're measuring

Patient Health Questionnaire (PHQ-9) depression scale

Timeframe: 8 Weeks

Rosenberg Self-Esteem Scale

Timeframe: 8 Weeks

State-Trait Anxiety Inventory (STAI)

Timeframe: 8 Weeks

Trial details

NCT IDNCT03013777

SponsorNYU Langone Health

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2018-07-20

View on ClinicalTrials.gov More Dysthymia trials